Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term, Open Label, Noncomparative Study to Evaluate the Safety of 0.1% Tacrolimus (FK506) Ointment for Treatment of Atopic Dermatitis

NCT00560378 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT00560378
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00560378 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term, Open Label, Noncomparative Study to Evaluate the Safety of 0.1% Tacrolimus (FK506) Ointment for Treatment of Atopic Dermatitis
Lead sponsor
Astellas Pharma Inc
Phase
Phase 3
Overall status
Completed
Start date
June 30, 1998
Completion date
June 30, 2005
Enrollment
789 (actual)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

dermatitis, atopic, eczema, atopic